Smartvalue Distribution
The computed 12-month bankruptcy probability of Smartvalue Distribution is 2.6% (moderate). The 2025 annual accounts show equity of €18k and a net result of €-32k. Its solvency ranks better than 34% of 185 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €18k |
| Net result | €-32k |
| Better than sector | 34% |
| Active | 2 yrs |
Fragile profile, watch profitability in particular.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 29.7% | 42.6% | |
| Net result | €-32k | €159k | |
| Equity | €18k | €1.19M | |
| Gross operating margin | €-31k | €188k | |
| Total assets | €60k | €3.26M |
| Fiscal year | 2025 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | - |
| Net profit | €-32k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €60k |
| Equity | €18k |
| Debt | €42k |
| of which ≤ 1y | €42k |
| of which > 1y | - |
| Working capital | €3k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 1.06 |
| Quick ratio | 0.41 |
| Working capital ratio | 4.4% |
| Solvency | 29.7% |
| Debt / equity | 2.37 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -54.0% |
| ROE | -181.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €60k |
| Fixed assets | 21/28 | €15k |
| Tangible fixed assets | 22/27 | €15k |
| Current assets | 29/58 | €44k |
| Stocks & contracts in progress | 3 | €27k |
| Amounts receivable within one year | 40/41 | €17k |
| Cash & bank | 54/58 | €487 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €60k |
| Equity | 10/15 | €18k |
| Contributions / capital | 10/11 | €50k |
| Accumulated profits (losses) | 14 | €-32k |
| Amounts payable | 17/49 | €42k |
| Amounts payable within one year | 42/48 | €42k |
| Trade debts payable within one year | 44 | €41k |
| Income statement | ||
| Gross operating margin | 9900 | €-31k |
| Operating result | 9901 | €-32k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €56 |
| Result before taxes | 9903 | €-32k |
| Net result for the period | 9904 | €-32k |
| Result to be appropriated | 9905 | €-32k |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 02-01-2024 |
| Status | Active |
| Postal code | 4020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62113B0166/00V000 | Wallonia | 2.8 ha | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-11-2024 2 directors appointed
- Emilie Van Callemont, Commissaris
- GJ Lifesciences management SRL, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Emilie Van Callemont",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "EY R\u00E9viseurs d\u0027Entreprises",
"address": "4000 Li\u00E8ge, rue des Guillemins 129, bo\u00EEte 3",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-11-30",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant que commissaire aux comptes la SRL EY R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge social est situ\u00E9 \u00E0 4000 Li\u00E8ge, rue des Guillemins 129, bo\u00EEte 3, repr\u00E9sent\u00E9e par Madame Emilie Van Callemont, avec effet au 30 novembre 2023, pour une dur\u00E9e de trois ans. Le mandat prendra ",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "future"
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "EY",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend acte que EY accepte le mandat de commissaire aux comptes et qu\u0027il n\u0027a fait l\u0027objet d\u0027aucune des incompatibilit\u00E9s pr\u00E9vues par les dispositions l\u00E9gales en vigueur.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": "0770.962.631",
"name": "GJ Lifesciences management SRL",
"address": "1082 Berchem-Sainte-Agathe, Avenue Ren\u00E9 Comhaire 80",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "niet_statutair",
"compensated": false,
"effective_date": "2023-11-30",
"evidence_quote": "Le Conseil d\u0027administration d\u00E9cide de d\u00E9l\u00E9guer la gestion journali\u00E8re, y compris la representation de la Soci\u00E9t\u00E9 en ce qui conceme cette gestion journali\u00E8re, \u00E0 la soci\u00E9t\u00E9 GJ Lifesciences management SRL, avec num\u00E9ro d\u0027entreprise 0770.962.631 et si\u00E8ge social \u00E0 1082 Berchem-Sainte-Agathe, Avenue Ren\u00E9 C",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "future"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2024-11-04",
"act_kind_objet": "Nomination de commissaire, procuration et d\u00E9l\u00E9gation journali\u00E8re"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-11-04",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "1004.124.303",
"name_full": "TRIBUNAL DE L\u0027ENTREPRISE DE LIEGE",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "GJ Lifesciences Management SRL",
"person_name": null,
"org_rep_person_name": "Jourquin Gilles",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Smartvalue Distribution |